loader
Please Wait
Applying Filters...

Fermion Oy Fermion Oy

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2019_106___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Zhuhai Rundu Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INTERMEDIATES

    PharmaCompass

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Zhuhai City CN (1)

    filter

    01 Valsartan (1)

    filter

    01 China (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    ZHUHAI RUNDU PHARMACEUTICAL CO., LT...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Valsartan

      PDF Supplier PDF
      URL Supplier Web Content
      CEP 2019-106 - Rev 02
      Valid
      Chemical
      2024-04-02
      2423
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for CEP 2019-106 - Rev 02 of Zhuhai Rundu Pharmaceutical Co., Ltd. Zhuhai City Cn

      Looking for Certificates of Suitability (CEPs) for CEP 2019-106 - Rev 02 of Zhuhai Rundu Pharmaceutical Co., Ltd. Zhuhai City Cn 1

      20

      Zhuhai Rundu Pharmaceutical Co., Ltd. Zhuhai City Cn, based in China, is a pharmaceutical company.

      One of their significant offerings is Valsartan, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2019-106 - Rev 02

      This Chemical Type CEP, issued on April 02, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

      Substance Number 2423 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY